Cargando…
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. M...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210354/ https://www.ncbi.nlm.nih.gov/pubmed/21947382 http://dx.doi.org/10.1007/s00125-011-2311-5 |
_version_ | 1782215727048032256 |
---|---|
author | Stephenne, X. Foretz, M. Taleux, N. van der Zon, G. C. Sokal, E. Hue, L. Viollet, B. Guigas, B. |
author_facet | Stephenne, X. Foretz, M. Taleux, N. van der Zon, G. C. Sokal, E. Hue, L. Viollet, B. Guigas, B. |
author_sort | Stephenne, X. |
collection | PubMed |
description | AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. METHODS: Hepatocytes isolated from rat, mouse and human livers were treated with various concentrations of metformin. Isoform-specific AMPKα abundance and activity, as well as intracellular adenine nucleotide levels and mitochondrial oxygen consumption rates were determined at different time points. RESULTS: Metformin dose- and time-dependently increased AMPK activity in rat and human hepatocytes, an effect associated with a significant rise in cellular AMP:ATP ratio. Surprisingly, we found that AMPKα2 activity was undetectable in human compared with rat hepatocytes, while AMPKα1 activities were comparable. Accordingly, metformin only increased AMPKα1 activity in human hepatocytes, although both AMPKα isoforms were activated in rat hepatocytes. Analysis of mRNA expression and protein levels confirmed that only AMPKα1 is present in human hepatocytes; it also showed that the distribution of β and γ regulatory subunits differed between species. Finally, we demonstrated that the increase in AMP:ATP ratio in hepatocytes from liver-specific Ampkα1/2 (also known as Prkaa1/2) knockout mice and humans is due to a similar and specific inhibition of the mitochondrial respiratory-chain complex 1 by metformin. CONCLUSIONS/INTERPRETATION: Activation of hepatic AMPK by metformin results from a decrease in cellular energy status owing to metformin’s AMPK-independent inhibition of the mitochondrial respiratory-chain complex 1. The unique profile of AMPK subunits found in human hepatocytes should be considered when developing new pharmacological agents to target the kinase. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-011-2311-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-3210354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-32103542011-11-28 Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status Stephenne, X. Foretz, M. Taleux, N. van der Zon, G. C. Sokal, E. Hue, L. Viollet, B. Guigas, B. Diabetologia Article AIM/HYPOTHESIS: The glucose-lowering drug metformin has been shown to activate hepatic AMP-activated protein kinase (AMPK), a master kinase regulating cellular energy homeostasis. However, the underlying mechanisms remain controversial and have never been investigated in primary human hepatocytes. METHODS: Hepatocytes isolated from rat, mouse and human livers were treated with various concentrations of metformin. Isoform-specific AMPKα abundance and activity, as well as intracellular adenine nucleotide levels and mitochondrial oxygen consumption rates were determined at different time points. RESULTS: Metformin dose- and time-dependently increased AMPK activity in rat and human hepatocytes, an effect associated with a significant rise in cellular AMP:ATP ratio. Surprisingly, we found that AMPKα2 activity was undetectable in human compared with rat hepatocytes, while AMPKα1 activities were comparable. Accordingly, metformin only increased AMPKα1 activity in human hepatocytes, although both AMPKα isoforms were activated in rat hepatocytes. Analysis of mRNA expression and protein levels confirmed that only AMPKα1 is present in human hepatocytes; it also showed that the distribution of β and γ regulatory subunits differed between species. Finally, we demonstrated that the increase in AMP:ATP ratio in hepatocytes from liver-specific Ampkα1/2 (also known as Prkaa1/2) knockout mice and humans is due to a similar and specific inhibition of the mitochondrial respiratory-chain complex 1 by metformin. CONCLUSIONS/INTERPRETATION: Activation of hepatic AMPK by metformin results from a decrease in cellular energy status owing to metformin’s AMPK-independent inhibition of the mitochondrial respiratory-chain complex 1. The unique profile of AMPK subunits found in human hepatocytes should be considered when developing new pharmacological agents to target the kinase. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-011-2311-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer-Verlag 2011-09-23 2011 /pmc/articles/PMC3210354/ /pubmed/21947382 http://dx.doi.org/10.1007/s00125-011-2311-5 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Stephenne, X. Foretz, M. Taleux, N. van der Zon, G. C. Sokal, E. Hue, L. Viollet, B. Guigas, B. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
title | Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
title_full | Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
title_fullStr | Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
title_full_unstemmed | Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
title_short | Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
title_sort | metformin activates amp-activated protein kinase in primary human hepatocytes by decreasing cellular energy status |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210354/ https://www.ncbi.nlm.nih.gov/pubmed/21947382 http://dx.doi.org/10.1007/s00125-011-2311-5 |
work_keys_str_mv | AT stephennex metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT foretzm metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT taleuxn metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT vanderzongc metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT sokale metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT huel metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT violletb metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus AT guigasb metforminactivatesampactivatedproteinkinaseinprimaryhumanhepatocytesbydecreasingcellularenergystatus |